Paper31346211
Synergy of therapeutic heterologous prime-boost hepatitis B vaccination with CpG-application to improve immune control of persistent HBV infection.
Kosinska AD and 8 others. Sci Rep, 2019. Cited by 32 papers, by iCite.
Cite this record
ConductScience Library. Synergy of therapeutic heterologous prime-boost hepatitis B vaccination with CpG-application to improve immune control of persistent HBV infection. Papers, record 31346211. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/31346211
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Synergy of therapeutic heterologous prime-boost hepatitis B vaccination with CpG-application to improve immune control of persistent HBV infection.
- PubMed
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Adjuvants, Immunologic | Major topic |
| Hepatitis B Vaccines | Major topic |
| Hepatitis B, Chronic | Major topic |
| Oligodeoxyribonucleotides | Major topic |
| Vaccination | Major topic |
| Animals | |
| CD4-Positive T-Lymphocytes | |
| CD8-Positive T-Lymphocytes | |
| Cells, Cultured | |
| Female | |
| Hepatitis B Core Antigens | |
| Liver | |
| Male | |
| Mice | |
| Vaccines, DNA | |
| Viral Vaccines |
Source PubMed
References32
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 26412123 | Effective intrahepatic CD8+ T-cell immune responses are induced by low but not high numbers of antigen-expressing hepatocytes. | Cell Mol Immunol | 2016 | https://conductscience.org/library/papers/26412123 | PubMed |
| 2 | 26292984 | Mouse Models of Hepatitis B Virus Pathogenesis. | Cold Spring Harb Perspect Med | 2015 | https://conductscience.org/library/papers/26292984 | PubMed |
| 3 | 8328741 | Effect of alpha-interferon treatment in patients with hepatitis B e antigen-positive chronic hepatitis B. A meta-analysis. | Ann Intern Med | 1993 | https://conductscience.org/library/papers/8328741 | PubMed |
| 4 | 28453967 | Therapeutic vaccination for chronic hepatitis B. | Curr Opin Virol | 2017 | https://conductscience.org/library/papers/28453967 | PubMed |
| 5 | 29877316 | Hepatitis B virus infection. | Nat Rev Dis Primers | 2018 | https://conductscience.org/library/papers/29877316 | PubMed |
| 6 | 26404698 | Functional classification of memory CD8(+) T cells by CX3CR1 expression. | Nat Commun | 2015 | https://conductscience.org/library/papers/26404698 | PubMed |
| 7 | 17095599 | An immunocompetent mouse model for the tolerance of human chronic hepatitis B virus infection. | Proc Natl Acad Sci U S A | 2006 | https://conductscience.org/library/papers/17095599 | PubMed |
| 8 | 22487943 | Foxp3+ regulatory T cells protect the liver from immune damage and compromise virus control during acute experimental hepatitis B virus infection in mice. | Hepatology | 2012 | https://conductscience.org/library/papers/22487943 | PubMed |
| 9 | 23468504 | Adeno-associated virus-mediated gene transfer leads to persistent hepatitis B virus replication in mice expressing HLA-A2 and HLA-DR1 molecules. | J Virol | 2013 | https://conductscience.org/library/papers/23468504 | PubMed |
| 10 | 24412289 | Hepatic immune regulation and its involvement in viral hepatitis infection. | Gastroenterology | 2014 | https://conductscience.org/library/papers/24412289 | PubMed |
| 11 | 12477811 | CD8(+) T cells mediate viral clearance and disease pathogenesis during acute hepatitis B virus infection. | J Virol | 2003 | https://conductscience.org/library/papers/12477811 | PubMed |
| 12 | 26416327 | Interferon-γ and Tumor Necrosis Factor-α Produced by T Cells Reduce the HBV Persistence Form, cccDNA, Without Cytolysis. | Gastroenterology | 2016 | https://conductscience.org/library/papers/26416327 | PubMed |
| 13 | 7666518 | High-level hepatitis B virus replication in transgenic mice. | J Virol | 1995 | https://conductscience.org/library/papers/7666518 | PubMed |
| 14 | 24557838 | Specific and nonhepatotoxic degradation of nuclear hepatitis B virus cccDNA. | Science | 2014 | https://conductscience.org/library/papers/24557838 | PubMed |
| 15 | 30801899 | Therapeutic vaccination for chronic hepatitis B: A systematic review and meta-analysis. | J Viral Hepat | 2019 | https://conductscience.org/library/papers/30801899 | PubMed |
| 16 | 19500964 | Heterologous prime-boost vaccination. | Curr Opin Immunol | 2009 | https://conductscience.org/library/papers/19500964 | PubMed |
| 17 | 15711573 | Toll-like receptor 3 promotes cross-priming to virus-infected cells. | Nature | 2005 | https://conductscience.org/library/papers/15711573 | PubMed |
| 18 | 30524897 | Induction of liver-specific intrahepatic myeloid cells aggregation expands CD8 T cell and inhibits growth of murine hepatoma. | Oncoimmunology | 2018 | https://conductscience.org/library/papers/30524897 | PubMed |
| 19 | 19302037 | The liver as a lymphoid organ. | Annu Rev Immunol | 2009 | https://conductscience.org/library/papers/19302037 | PubMed |
| 20 | 25673700 | Inflammatory monocytes recruited to the liver within 24 hours after virus-induced inflammation resemble Kupffer cells but are functionally distinct. | J Virol | 2015 | https://conductscience.org/library/papers/25673700 | PubMed |
Cited by20
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 32 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41909658 | Therapeutic hepatitis B vaccine employing DNA prime - MVA boost scheme requires additional priming with recombinant HBsAg to elicit an adequate antibody response. | Front Immunol | 2026 | https://conductscience.org/library/papers/41909658 | PubMed |
| 41893803 | Protein Priming Followed by a Replication-Competent VSV-GP Vector Boost Induces Sustained Immune Control in Therapeutic Hepatitis B Vaccination. | Vaccines (Basel) | 2026 | https://conductscience.org/library/papers/41893803 | PubMed |
| 40799509 | MVA-HBVac-A novel vaccine vector that allows pan-genotypic targeting of hepatitis B virus by therapeutic vaccination. | Mol Ther Nucleic Acids | 2025 | https://conductscience.org/library/papers/40799509 | PubMed |
| 40382583 | Next-generation immunotherapeutic approaches for blood cancers: Exploring the efficacy of CAR-T and cancer vaccines. | Exp Hematol Oncol | 2025 | https://conductscience.org/library/papers/40382583 | PubMed |
| 38987588 | A liver immune rheostat regulates CD8 T cell immunity in chronic HBV infection. | Nature | 2024 | https://conductscience.org/library/papers/38987588 | PubMed |
| 38425450 | Introducing adjuvant-loaded particulate hepatitis B core antigen as an alternative therapeutic hepatitis B vaccine component. | JHEP Rep | 2024 | https://conductscience.org/library/papers/38425450 | PubMed |
| 36985174 | Dynamics of Hepatitis B Virus Covalently Closed Circular DNA: A Mini-Review. | Microorganisms | 2023 | https://conductscience.org/library/papers/36985174 | PubMed |
| 36851121 | Evaluation of the Effect of CD70 Co-Expression on CD8 T Cell Response in Protein-Prime MVA-Boost Vaccination in Mice. | Vaccines (Basel) | 2023 | https://conductscience.org/library/papers/36851121 | PubMed |
| 36714793 | Efficient stabilization of therapeutic hepatitis B vaccine components by amino-acid formulation maintains its potential to break immune tolerance. | JHEP Rep | 2023 | https://conductscience.org/library/papers/36714793 | PubMed |
| 36405686 | Activation of distinct antiviral T-cell immunity: A comparison of bi- and trispecific T-cell engager antibodies with a chimeric antigen receptor targeting HBV envelope proteins. | Front Immunol | 2022 | https://conductscience.org/library/papers/36405686 | PubMed |
| 36203595 | HBV immune tolerance of HBs-transgenic mice observed through parabiosis with WT mice. | Front Immunol | 2022 | https://conductscience.org/library/papers/36203595 | PubMed |
| 35229055 | Revival of the heterologous prime-boost technique in COVID-19: An outlook from the history of outbreaks. | Health Sci Rep | 2022 | https://conductscience.org/library/papers/35229055 | PubMed |
| 35059620 | Humoral immunity in hepatitis B virus infection: Rehabilitating the B in HBV. | JHEP Rep | 2022 | https://conductscience.org/library/papers/35059620 | PubMed |
| 34835264 | Improving Therapeutic Vaccination against Hepatitis B-Insights from Preclinical Models of Immune Therapy against Persistent Hepatitis B Virus Infection. | Vaccines (Basel) | 2021 | https://conductscience.org/library/papers/34835264 | PubMed |
| 34451966 | Immunogenicity and Antiviral Response of Therapeutic Hepatitis B Vaccination in a Mouse Model of HBeAg-Negative, Persistent HBV Infection. | Vaccines (Basel) | 2021 | https://conductscience.org/library/papers/34451966 | PubMed |
| 33992859 | Innate immunity and HBV persistence. | Curr Opin Virol | 2021 | https://conductscience.org/library/papers/33992859 | PubMed |
| 33489122 | Designing the next-generation therapeutic vaccines to cure chronic hepatitis B: focus on antigen presentation, vaccine properties and effect measures. | Clin Transl Immunology | 2021 | https://conductscience.org/library/papers/33489122 | PubMed |
| 32466788 | HBV X protein-based therapeutic vaccine accelerates viral antigen clearance by mobilizing monocyte infiltration into the liver in HBV carrier mice. | J Biomed Sci | 2020 | https://conductscience.org/library/papers/32466788 | PubMed |
| 32131853 | A novel TLR7 agonist as adjuvant to stimulate high quality HBsAg-specific immune responses in an HBV mouse model. | J Transl Med | 2020 | https://conductscience.org/library/papers/32131853 | PubMed |
| 31809638 | Designing a therapeutic hepatitis B vaccine to circumvent immune tolerance. | Hum Vaccin Immunother | 2020 | https://conductscience.org/library/papers/31809638 | PubMed |
Genes13
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/31346211
GET https://conductscience.org/api/papers/v1/31346211/references?page=2